nach oben

Drugs & Aging

Erschienen in:

01.06.2000 | Review Article

Assessing Medication Appropriateness in the Elderly

A Review of Available Measures

verfasst von: Dr Penny S. Shelton, Michelle A. Fritsch, Mollie A. Scott

Erschienen in: Drugs & Aging | Ausgabe 6/2000

Einloggen, um Zugang zu erhalten

Abstract

The disproportionate use of medications, combined with age-related pharmacokinetic and pharmacodynamic changes, places older adults at high risk for medication related problems (MRPs). MRPs demonstrate significant morbidity, mortality and economic impact among healthcare systems. The negative outcomes associated with MRPs emphasise the need for more careful and thorough assessments of drug therapy among older adults.

In the 1990s a number of methods and instruments were developed to assist in the assessment of medication appropriateness. These tools may be categorised by criteria as: implicit, explicit or one utilising a combination of implicit and explicit criteria. This article reviews these available tools and outlines the advantages and disadvantages of each. In conclusion, those instruments considered to be comprised of both implicit and explicit criteria offer a more thorough assessment of medication appropriateness.

Hall WJ. Update in geriatrics. Ann Intern Med 1997; 127(7): 557–64PubMed

Stewart RB. Drag use in the elderly. In: Delafuente JC, Stewart RB, editors. Therapeutics in the elderly. 2nd ed. Cincinnati: Harvey Whitney Books, 1995: 174–89

Broderick E. Prescribing patterns for nursing home residents in the US: the reality and the vision. Drags Aging 1997; 11: 255–60CrossRef

Chrischilles EA, Foley DJ, Wallace RB, et al. Use of medications by persons 65 and over: data from the Established Populations for Epidemiologic Studies of the Elderly. J Gerontol 1992; 47: M137–44PubMedCrossRef

Chrischilles EA, Segar ET, Wallace RB. Self-reported adverse drag reactions and related resource use: a study of community-dwelling persons 65 years of age and older. Ann Intern Med 1992; 117: 634–40PubMed

Hanlon JT, Schmader KE, Koronkowski MJ, et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1997; 45: 945–8PubMed

May JR. Adverse drug reactions and interactions. In: Dipiro JT, Talbert RL, Yee GC, et al., editors. Pharmacotherapy: apathophysiologic approach. 3rd ed. Stamford: Appleton and Lange, 1997: 101–16

Rochon PA, Gurwitz JH. Optimising drag treatment for elderly people: the prescibing cascade. BMJ 1997; 315: 1096–9PubMedCrossRef

Graves T, Hanlon JT, Schmader KE, et al. Adverse events after discontinuing medications in elderly outpatients. Arch Intern Med 1997; 157: 2205–10PubMedCrossRef

10.

Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients: excess length of stay, extra costs and attributable mortality. JAMA 1997; 277(4): 301–6PubMedCrossRef

11.

Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200–5PubMedCrossRef

12.

Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med 1995; 155: 1949–56PubMedCrossRef

13.

Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drag events: implications for prevention. JAMA 1995; 274: 29–34PubMedCrossRef

14.

Beers MH, Storrie M, Lee G. Potential adverse drag interactions in the emergency room: an issue in the quality of care. Ann Intern Med 1990; 112: 61–4PubMed

15.

Costa AJ. Potential drug interactions in an ambulatory geriatric population. Fam Practice 1991; 8: 234–6CrossRef

16.

Gosney M, Tallis R. Prescription of contraindicated and interacting drugs in elderly patients admitted to hospital. Lancet 1984; II: 564–7CrossRef

17.

Jankel CA, McMillan JA, Martin BC. Effect of drag interactions on outcomes of patients receiving warfarin or theophylline. Am J Hosp Pharm 1994; 51: 661–6PubMed

18.

Hamilton RA, Gordon T. Incidence and cost of hospital admissions secondary to drug interactions involving theophylline. Ann Pharmacother 1992; 26: 1507–11PubMed

19.

Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997; 157: 1531–6PubMedCrossRef

20.

Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994; 330: 592–6PubMedCrossRef

21.

Perez-Stable EJ, Miranda J, Munoz RF, et al. Depression in medical outpatients: underrecognition and misdiagnosis. Arch Intern Med 1990; 150: 1083–8PubMedCrossRef

22.

Gurwitz JH, Monette J, Rochon PA, et al. Atrial fibrillation and stroke prevention with warfarin the long-term care setting. Arch Intern Med 1997; 157: 978–84PubMedCrossRef

23.

Stuck AE, Tamai IY. Medication management in the home. Clin Geriatr Med 1991; 7(4): 733–48PubMed

24.

Monane M, Monane S, Semla T. Optimal medication use in elders: key to successful aging. West J Med 1997; 167: 233–7PubMed

25.

Montamat SC, Cusack BJ, Vestal RE. Management of drag therapy in the elderly. N Engl J Med 1989; 321: 303–9PubMedCrossRef

26.

Beers MH, Ouslander JG, Fingold SF, et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992; 117: 684–9PubMed

27.

Spore DL, Mor V, Larrat P, et al. Inappropriate drag prescriptions for elderly residents of board and care facilities. Am J Pub Health 1997; 87: 404–9CrossRef

28.

Aparasu RR, Fliginger SE. Inappropriate medication prescribing for the elderly by office-based physicians. Ann Pharmacother 1997; 31: 823–9PubMed

29.

Tamblyn RM, McLeod PJ, Abrahamowicz M, et al. Questionable prescribing for elderly patients in Quebec. Can Med Assoc J 1994; 150(11): 1801–9

30.

Torrible SJ, Hogan DB. Medication use and rural seniors: who really knows what they are taking? Can Fam Physician 1997; 43: 893–989PubMed

31.

Der EH, Rubenstein LZ, Choy GS. The benefits of in-home pharmacy evaluation for older persons. J Am Geriatr Soc 1997; 45(2): 211–4

32.

Hunter KA, Florio ER, Langberg RG. Pharmaceutical care for home-dwelling elderly persons: a determination of need and program description. Gerontologist 1996; 36(4): 543–8PubMedCrossRef

33.

Schrader SL, Dressing B, Blue R, et al. The Medication Reduction Project: combatting polypharmacy in South Dakota elders through community-based interventions. S D J Med 1996; 49(12): 441–8PubMed

34.

Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med 1991; 151: 1825–32PubMedCrossRef

35.

Shelton PS, Hanlon JT, Landsman PB, et al. Reliability of drug utilization evaluation as an assessment of medication appropriateness. Ann Pharmacother 1997; 31: 533–42PubMed

36.

Morris JN, Hawes C, Murphy K, et al. Resident assessment instrument training manual and resource guide. Natick (MA): Eliot Press, 1991

37.

Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45: 1045–51PubMedCrossRef

38.

Hamdy RC, Moore SW, Whalen K, et al. Reducing polypharmacy in extended care. South Med J 1995; 88(5): 534–8PubMedCrossRef

39.

Owens NJ, Sherburne NJ, Silliman RA, et al. The Senior Care Study: the optimal use of medications in acutely ill older patients. J Am Geriatr Soc 1990; 38: 1082–7PubMed

40.

Johnson RE, Campbell WH, Azevedo DJ, et al. Studying the impact of patient drag profiles in an HMO. Med Care 1976; 14: 799–807PubMedCrossRef

41.

Koepsell TD, Gurtel AL, Diehr PH, et al. The Seattle evaluation of computerized drag profiles: effects on prescribing practice and resource use. Am J Pub Health 1983; 73: 850–5CrossRef

42.

Tamai IY, Rubenstein LZ, Josephson KR, et al. Impact of computerized drag profiles and a consulting pharmacist on outpatient prescribing patterns: a clinical trial. Drag Intell Clin Pharm 1987; 21: 890–5

43.

Stuck AE, Beers MH, Steiner A, et al. Inappropriate medication use in community-residing older persons. Arch Intern Med 1994; 154: 2195–200PubMedCrossRef

44.

Anderson GM, Beers MH, Kerluke K. Auditing prescription practice using explicit criteria and computerized drug benefit claims data. J Evalu Clin Pract 1997; 3(4): 283–94CrossRef

45.

Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA 1994; 272(4): 292–6PubMedCrossRef

46.

McLeod PJ, Huang AR, Tamblyn RM, et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. Can Med Assoc J 1997; 156(3): 385–91

47.

Oborne CA, Batty GM, Maskrey V, et al. Development of prescribing indicators for elderly medical inpatients. Br J Clin Pharmacol 1997; 43: 91–7PubMedCrossRef

48.

Knapp DA. Development of criteria for drug utilization review. Clin Pharm Ther 1991; 50(5): 600–5

49.

Davidson HE, Chamberlain TM, Hernandez P, et al. Drug-use evaluation, part II: Drug-use analysis in pharmaceutical care and quality assurance. Consult Pharmacist 1991; 6(10): 836–43

50.

Ben-Joseph R, Segal R, Russell WL, et al. Evaluating the value, accuracy and operational feasibility of DUE criteria. Formulary 1995; 30: 280–3PubMed

51.

Winslade NE, Bajcare JM, Bombassaro AM, et al. Pharmacist’s management of drug-related problems: a tool for teaching and providing pharmaceutical care. Pharmacotherapy 1997; 17(4): 801–9PubMed

52.

Robertson KE. Process for preventing or identifying and resolving problems in drug therapy. Am J Health Syst Pharm 1996; 53: 639–50PubMed

53.

Newton PF, Levinson W, Maslen D. The Geriatric Medication Algorithm: a pilot study. J Gen Intern Med 1994; 9(3): 164–7PubMedCrossRef

54.

Lipton HL, Bird JA, Bero LA, et al. Assessing the appropriateness of physician prescribing for geriatric outpatients: development and testing of an instrument. J Pharm Technol 1993; 9: 107–13PubMed

55.

Owens NJ, Fretwell MD, Willey C, et al. Distinquishing between the fit and frail elderly, and optimising pharmacotherapy. Drugs Aging 1994; 4(1): 47–55PubMedCrossRef

56.

Morris JN, Hawes C, Fries BE, et al. Designing the national resident assessment instrument for nursing homes. Gerontologist 1990; 30: 293–307PubMedCrossRef

57.

Riley K. Putting the MDS 2.0 to work in long-term care. Consult Pharmacist 1996; 11(7): 669–75

58.

Riley K. RAPs and the consultant pharmacist. Consult Pharmacist 1997; 12(1): 32–4

59.

Morris JN, Fries BE, Knight S, et al. Comprehensive clinical assessment in community setting: applicability of the MDSHC. J Am Geriatr Soc 1997; 45: 1017–24PubMed

60.

Morris JN, Nonemaker S, Murphy K, et al. A commitment to change: revision of HCFA’s RAI. J Am Geriatr Soc 1997; 45: 1011–16PubMed

61.

Ouslander JG. The resident assessment instrument (RAI): promises and pitfalls. J Am Geriatr Soc 1997; 45: 975–6PubMed

62.

Losben NL. Putting the MDS 2.0 to work to identify and monitor at-risk elderly. Consult Pharmacist 1997; 12(5): 520–34

63.

Tobias DE, Feinberg JL, Troutman WG. The MDS-Med Guide: a tool for the new millenium. Consult Pharmacist 1999; 14(8): 831–60

64.

Samsa GP, Hanlon JT, Schmader KE, et al. A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol 1994; 47: 891–6PubMedCrossRef

65.

Schmader KE, Hanlon JT, Weinberger M, et al. Appropriateness of medication prescribing in ambulatory elderly patients. J Am Geriatr Soc 1994; 42: 1241–7PubMed

66.

Schmader KE, Hanlon JT, Landsman PB, et al. Inappropriate prescribing and health outcomes in elderly veteran outpatients. Ann Pharmacother 1997; 31: 529–33PubMed

67.

Fitzgerald LS, Hanlon JT, Shelton PS, et al. Reliability of a modified medication appropriateness index in ambulatory older persons. Ann Pharmacother 1997; 31: 543–8PubMed

68.

Naranjo CA, Busto U, Sellers EM. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239–45PubMedCrossRef

69.

Kramer MS, Leventhal JM, Hutchinson TA, et al. An algorithm for the operational assessment of adverse drug reactions. J Am Med Assoc 1979; 242: 623–32CrossRef

70.

Hepler DC, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47: 533–43PubMed

Titel: Assessing Medication Appropriateness in the Elderly
A Review of Available Measures
verfasst von: Dr Penny S. Shelton
Michelle A. Fritsch
Mollie A. Scott
Publikationsdatum: 01.06.2000
Verlag: Springer International Publishing
Erschienen in: Drugs & Aging / Ausgabe 6/2000
Print ISSN: 1170-229X
Elektronische ISSN: 1179-1969
DOI: https://doi.org/10.2165/00002512-200016060-00004

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Assessing Medication Appropriateness in the Elderly

A Review of Available Measures

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2000

Potential Role of Cannabinoids in Parkinson’s Disease

Risperidone

Onychomycosis in the Elderly

Use of Oral Anticoagulants in Older Patients

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin